Mallory Makowsky

3.0k total citations
4 papers, 167 citations indexed

About

Mallory Makowsky is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mallory Makowsky has authored 4 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 1 paper in Surgery and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Mallory Makowsky's work include Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Mallory Makowsky is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Mallory Makowsky collaborates with scholars based in United States, Spain and Japan. Mallory Makowsky's co-authors include Ghassan K. Abou‐Alfa, Bruno Sangro, Mitesh J. Borad, Feng Xiao, Wei Peng Yong, Shannon R. Morris, Johanna C. Bendell, Robin Kate Kelley, Yoon‐Koo Kang and Tae‐You Kim and has published in prestigious journals such as Journal of Clinical Oncology and PubMed.

In The Last Decade

Mallory Makowsky

4 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mallory Makowsky United States	4	129	108	46	42	28	4	167
Derek-Zhen Xu China	5	124 1.0×	91 0.8×	47 1.0×	32 0.8×	28 1.0×	6	171
Marta Piqué‐Gili United Kingdom	4	75 0.6×	54 0.5×	34 0.7×	22 0.5×	26 0.9×	4	125
Yabing Guo China	8	179 1.4×	87 0.8×	36 0.8×	33 0.8×	27 1.0×	15	270
Erik Ramon‐Gil United Kingdom	3	72 0.6×	52 0.5×	35 0.8×	28 0.7×	25 0.9×	5	126
Magdalena Żotkiewicz United States	3	91 0.7×	68 0.6×	40 0.9×	14 0.3×	36 1.3×	7	162
Éric Assenat France	7	113 0.9×	83 0.8×	24 0.5×	12 0.3×	40 1.4×	18	167
Zuojun Zhen China	7	55 0.4×	58 0.5×	21 0.5×	17 0.4×	25 0.9×	16	158
Yamil Alonso Lopez Chuken Mexico	3	84 0.7×	32 0.3×	29 0.6×	9 0.2×	21 0.8×	6	103
Shreya Badhrinarayanan United Kingdom	5	51 0.4×	54 0.5×	12 0.3×	27 0.6×	15 0.5×	7	102
Bernardo Stefanini Italy	7	85 0.7×	44 0.4×	27 0.6×	15 0.4×	36 1.3×	32	172

Countries citing papers authored by Mallory Makowsky

Since Specialization

Citations

This map shows the geographic impact of Mallory Makowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallory Makowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallory Makowsky more than expected).

Fields of papers citing papers by Mallory Makowsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallory Makowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallory Makowsky. The network helps show where Mallory Makowsky may publish in the future.

Co-authorship network of co-authors of Mallory Makowsky

This figure shows the co-authorship network connecting the top 25 collaborators of Mallory Makowsky. A scholar is included among the top collaborators of Mallory Makowsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallory Makowsky. Mallory Makowsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Lau, George, Ann‐Lii Cheng, Bruno Sangro, et al.. (2023). Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).. Journal of Clinical Oncology. 41(16_suppl). 4004–4004. 8 indexed citations

2.

Lau, George, Bruno Sangro, Oxana Crysler, et al.. (2023). Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).. Journal of Clinical Oncology. 41(16_suppl). 4073–4073. 4 indexed citations

3.

Kelley, Robin Kate, Ghassan K. Abou‐Alfa, Johanna C. Bendell, et al.. (2017). Phase I/II study of durvalumab and tremelimumab in patients with unresectable hepatocellular carcinoma (HCC): Phase I safety and efficacy analyses.. Journal of Clinical Oncology. 35(15_suppl). 4073–4073. 143 indexed citations

4.

Makowsky, Mallory, et al.. (1999). Contested claims in carpal tunnel surgery: outcome study of worker's compensation factors.. PubMed. 19. 111–21. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact